Skip to main content

Table 2 Comparison of age-standardized incidence, mortality, prevalence, YLL, YLD, and DALY rates of lymphoma between in China and in the world, 2016

From: Burden of lymphoma in China, 2006–2016: an analysis of the Global Burden of Disease Study 2016

Variable (per 100,000)Hodgkin’s lymphomaNon-Hodgkin’s lymphoma
ChinaWorldChinaWorld
ASIR0.46 (0.36–0.57)1.33 (1.16–1.56)4.29 (3.61–4.52)6.34 (6.24–6.44)
ASMR0.19 (0.16–0.25)0.43 (0.36–0.50)2.45 (2.06–2.61)3.24 (3.18–3.30)
ASPR1.75 (1.35–2.13)8.63 (7.48–10.29)14.94 (12.64–15.82)30.75 (30.28–31.23)
Age-standardized YLLs5.77 (4.79–7.61)17.66 (14.77–20.84)69.27 (58.65–73.96)89.56 (87.26–91.73)
Age-standardized YLDs0.18 (0.13–0.26)0.66 (0.46–0.90)1.40 (0.96–1.89)2.51 (1.83–3.29)
Age-standardized DALYs5.95 (4.94–7.83)18.32 (15.36–21.62)70.67 (59.87–75.38)92.07 (89.58–94.40)
  1. ASIR age-standardized incidence rate, ASMR age-standardized mortality rate, ASPR age-standardized prevalence rate, DALYs disability-adjusted life years, YLDs years lived with disability, YLLs years of life lost
  2. Data in parentheses are 95% uncertainty intervals